Skip to main content
Top
Published in: Current Infectious Disease Reports 3/2013

01-06-2013 | Pediatric Infectious Diseases (I Brook, Section Editor)

Penicillin Failure in the Treatment of Streptococcal Pharyngo-Tonsillitis

Author: Itzhak Brook

Published in: Current Infectious Disease Reports | Issue 3/2013

Login to get access

Abstract

The inadequate penetration of penicillins into the tonsillar tissues and tonsillar surface fluid and microbiologic interactions between Group A beta-hemolytic streptococci (GABHS) and other pharyngo-tonsillar bacterial flora can account for their failure in eradicating GABHS pharyngo-tonsillitis (PT). These interactions include the presence of beta-lactamase producing bacteria (BLPB) that “shield” GABHS from penicillins, the absence of bacteria that interfere with the growth of GABHS, and the coaggregation between GABHS and Moraxella catarrhalis. In the treatment of acute tonsillitis, the use of cephalosporins can overcome these interactions by eradicating aerobic BLPB, while preserving the potentially interfering organisms and eliminating GABHS. In treatment of recurrent and chronic PT, the administration of clindamycin or amoxicillin-clavulanatecan eradicates both aerobic and anaerobic BLPB, as well as GABHS.
Literature
1.
go back to reference Pichichero ME, Casey JR. The evidence base for cephalosporin superiority over penicillin in streptococcal pharyngitis. Diagn Microbiol Infect Dis. 2007;57(Supplement):S39–45. Pichichero ME, Casey JR. The evidence base for cephalosporin superiority over penicillin in streptococcal pharyngitis. Diagn Microbiol Infect Dis. 2007;57(Supplement):S39–45.
2.
go back to reference Kaplan EL, Chatwal GS, Rohde M. Reduced ability of penicillin to eradicate ingested Group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis. 2006;43:1398–406.PubMedCrossRef Kaplan EL, Chatwal GS, Rohde M. Reduced ability of penicillin to eradicate ingested Group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis. 2006;43:1398–406.PubMedCrossRef
3.
go back to reference Brook I. Role of beta-lactamase–producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis. 1984;6:601–7.PubMedCrossRef Brook I. Role of beta-lactamase–producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis. 1984;6:601–7.PubMedCrossRef
4.
go back to reference Lafontaine ER, Wall D, Vanlerberg SL, Donabedian H, Sledjeski DD. Moraxella catarrhalis coaggregates with Streptococcus pyogenes and modulates interactions of S pyogenes with human epithelial cells. Infect Immun. 2004;72:6689–93.PubMedCrossRef Lafontaine ER, Wall D, Vanlerberg SL, Donabedian H, Sledjeski DD. Moraxella catarrhalis coaggregates with Streptococcus pyogenes and modulates interactions of S pyogenes with human epithelial cells. Infect Immun. 2004;72:6689–93.PubMedCrossRef
5.
go back to reference Grahn E, Holm SE. Bacterial interference in the throat flora during a pharyngo- tonsillitis outbreak in an apartment house area. Zbl Bakl Hyg A. 1983;256:72–9. Grahn E, Holm SE. Bacterial interference in the throat flora during a pharyngo- tonsillitis outbreak in an apartment house area. Zbl Bakl Hyg A. 1983;256:72–9.
6.
go back to reference Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg. 2005;133(1):139–46. Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg. 2005;133(1):139–46.
7.
go back to reference Neeman R, Keller N, Barzilai A, Korenman Z, Sela S. Prevalence of internalization-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet. 1998;352:1974–7.PubMedCrossRef Neeman R, Keller N, Barzilai A, Korenman Z, Sela S. Prevalence of internalization-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet. 1998;352:1974–7.PubMedCrossRef
8.
go back to reference Stjernquist-Desatnik A, Samuelsson P, Walder M. Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis. J Laryngol Otol. 1993;107:309–12.PubMedCrossRef Stjernquist-Desatnik A, Samuelsson P, Walder M. Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis. J Laryngol Otol. 1993;107:309–12.PubMedCrossRef
9.
go back to reference Marouni MJ, Barzilai A, Keller N, Rubinstein E, Sela S. Intracellular survival of persistent Group A streptococci in cultured epithelial cells. Int J Med Microbiol. 2004;294:27–33.PubMedCrossRef Marouni MJ, Barzilai A, Keller N, Rubinstein E, Sela S. Intracellular survival of persistent Group A streptococci in cultured epithelial cells. Int J Med Microbiol. 2004;294:27–33.PubMedCrossRef
10.
go back to reference Orrling A, Kamme C, Stjernquist-Desatnik A. Penicillin V, loracarbef and clindamycin in tonsillar surface fluid during acute Group A streptococcal pharyngotonsillitis. Scand J Infect Dis. 2005;37:429–35.PubMedCrossRef Orrling A, Kamme C, Stjernquist-Desatnik A. Penicillin V, loracarbef and clindamycin in tonsillar surface fluid during acute Group A streptococcal pharyngotonsillitis. Scand J Infect Dis. 2005;37:429–35.PubMedCrossRef
11.
go back to reference Brook I. Emergence and persistence of beta-lactamase–producing bacteria in the oropharynx following penicillin treatment. Arch Otolaryngol Head Neck Surg. 1988;114:667–70.PubMedCrossRef Brook I. Emergence and persistence of beta-lactamase–producing bacteria in the oropharynx following penicillin treatment. Arch Otolaryngol Head Neck Surg. 1988;114:667–70.PubMedCrossRef
12.
go back to reference Brook I. Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate Group A strepharyngo-tonsillitisococci. Pediatr Infect Dis. 1985;4:491–5.PubMedCrossRef Brook I. Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate Group A strepharyngo-tonsillitisococci. Pediatr Infect Dis. 1985;4:491–5.PubMedCrossRef
13.
go back to reference Brook I, Gober AE. Failure to eradicate streptococci and beta-lactamase producing bacteria. Acta Paediatr. 2008;96:193–5.CrossRef Brook I, Gober AE. Failure to eradicate streptococci and beta-lactamase producing bacteria. Acta Paediatr. 2008;96:193–5.CrossRef
14.
go back to reference Brook I, Yocum P, Friedman EM. Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis. Ann Otol Rhinol Laryngol. 1981;90:261–3.PubMed Brook I, Yocum P, Friedman EM. Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis. Ann Otol Rhinol Laryngol. 1981;90:261–3.PubMed
15.
go back to reference Taylan I, Ozcan I, Mumcuoğlu I, Baran I, Murat Özcan K, Akdoğan O, et al. Comparison of the surface and core bacteria in tonsillar and adenoid tissue with beta-lactamase production. Indian J Otolaryngol Head Neck Surg. 2011;63:223–8.PubMedCrossRef Taylan I, Ozcan I, Mumcuoğlu I, Baran I, Murat Özcan K, Akdoğan O, et al. Comparison of the surface and core bacteria in tonsillar and adenoid tissue with beta-lactamase production. Indian J Otolaryngol Head Neck Surg. 2011;63:223–8.PubMedCrossRef
16.
go back to reference Reilly S, Timmis P, Beeden AG, Willis AT. Possible role of the anaerobe in tonsillitis. J Clin Pathol. 1981;34:542–7.PubMedCrossRef Reilly S, Timmis P, Beeden AG, Willis AT. Possible role of the anaerobe in tonsillitis. J Clin Pathol. 1981;34:542–7.PubMedCrossRef
17.
go back to reference Tuner K, Nord CE. Beta-lactamase–producing anaerobic bacteria in recurrent tonsillitis. J Antimicrob Chemother. 1982;10(suppl A):153–6.PubMedCrossRef Tuner K, Nord CE. Beta-lactamase–producing anaerobic bacteria in recurrent tonsillitis. J Antimicrob Chemother. 1982;10(suppl A):153–6.PubMedCrossRef
18.
go back to reference Chagollan J, Macias JR, Gil JS. Flora indigena de las amigdales. Invest Med Int. 1984;11:36–9. Chagollan J, Macias JR, Gil JS. Flora indigena de las amigdales. Invest Med Int. 1984;11:36–9.
19.
go back to reference Kielmovitch IH, Keleti G, Bluestone CD, Wald ER, Gonzales C. Microbiology of obstructive tonsillar hypertrophy and recurrent tonsillitis. Arch Otolaryngol Head Neck Surg. 1989;115:721–5.PubMedCrossRef Kielmovitch IH, Keleti G, Bluestone CD, Wald ER, Gonzales C. Microbiology of obstructive tonsillar hypertrophy and recurrent tonsillitis. Arch Otolaryngol Head Neck Surg. 1989;115:721–5.PubMedCrossRef
20.
go back to reference Brook I, Yocum P, Foote Jr PA. Changes in the core tonsillar bacteriology of recurrent tonsillitis, 1977–1993. Clin Infect Dis. 1995;21:171–6.PubMedCrossRef Brook I, Yocum P, Foote Jr PA. Changes in the core tonsillar bacteriology of recurrent tonsillitis, 1977–1993. Clin Infect Dis. 1995;21:171–6.PubMedCrossRef
21.
go back to reference Brook I, Yocum P. Quantitative measurement of beta-lactamase level in tonsils of children with recurrent tonsillitis. Acta Otolaryngol Scand. 1984;98:446–60. Brook I, Yocum P. Quantitative measurement of beta-lactamase level in tonsils of children with recurrent tonsillitis. Acta Otolaryngol Scand. 1984;98:446–60.
22.
go back to reference Brook I. Beta-lactamase-producing bacteria and their role in infection. Rev Med Microbiol. 2005;16:91–9.CrossRef Brook I. Beta-lactamase-producing bacteria and their role in infection. Rev Med Microbiol. 2005;16:91–9.CrossRef
23.
go back to reference Brook I. Treatment of patients with acute recurrent tonsillitis due to Group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxicillin/clavulanate potassium. J Antimicrob Chemother. 1989;24:227–33.PubMedCrossRef Brook I. Treatment of patients with acute recurrent tonsillitis due to Group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxicillin/clavulanate potassium. J Antimicrob Chemother. 1989;24:227–33.PubMedCrossRef
24.
go back to reference Kaplan EL, Johnson DR. Eradication of Group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr. 1988;113:400–3.PubMedCrossRef Kaplan EL, Johnson DR. Eradication of Group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr. 1988;113:400–3.PubMedCrossRef
25.
go back to reference Holm S, Henning C, Grahn E, Lomberg H, Staley H. Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish Study Group. Scand J Infect Dis. 1995;27:221–8.PubMedCrossRef Holm S, Henning C, Grahn E, Lomberg H, Staley H. Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish Study Group. Scand J Infect Dis. 1995;27:221–8.PubMedCrossRef
26.
go back to reference Holm SE, Roos K, Stromberg A. A randomized study of treatment of streptococcal pharyngotonsillitis with cefadroxil or phenoxymethylpenicillin (penicillin V). Pediatr Infect Dis J. 1991;10:S68–71.PubMedCrossRef Holm SE, Roos K, Stromberg A. A randomized study of treatment of streptococcal pharyngotonsillitis with cefadroxil or phenoxymethylpenicillin (penicillin V). Pediatr Infect Dis J. 1991;10:S68–71.PubMedCrossRef
27.
go back to reference Socransky SS, Manganiello SD. The oral microflora of man from birth to senility. J Periodontol. 1971;42:485–96.PubMedCrossRef Socransky SS, Manganiello SD. The oral microflora of man from birth to senility. J Periodontol. 1971;42:485–96.PubMedCrossRef
28.
go back to reference Brook I, Gober AE. Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate Group A streptococcal pharyngotonsillitis. Arch Otolaryngol Head Neck Surg. 1995;121:1405–9.PubMedCrossRef Brook I, Gober AE. Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate Group A streptococcal pharyngotonsillitis. Arch Otolaryngol Head Neck Surg. 1995;121:1405–9.PubMedCrossRef
29.
go back to reference Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg. 2005;133:139–46.PubMedCrossRef Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg. 2005;133:139–46.PubMedCrossRef
30.
go back to reference Brook I, Gober AE. Bacterial interference by aerobic and anaerobic bacteria in children with recurrent Group A beta-hemolytic streptococcal tonsillitis. Arch Otolaryngol Head Neck Surg. 1999;125:552–4.PubMed Brook I, Gober AE. Bacterial interference by aerobic and anaerobic bacteria in children with recurrent Group A beta-hemolytic streptococcal tonsillitis. Arch Otolaryngol Head Neck Surg. 1999;125:552–4.PubMed
31.
go back to reference Roos K, Grahn E, Holm SE, Johansson H, Lind L. Interfering alpha- streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otol. 1993;25:141–8.CrossRef Roos K, Grahn E, Holm SE, Johansson H, Lind L. Interfering alpha- streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otol. 1993;25:141–8.CrossRef
32.
go back to reference Roos K, Holm SE, Grahn E, Lind L. Alpha-strepharyngo-tonsillitisococci as supplementary treatment of recurrent pharyngo-tonsillitis: a randomized placebo-controlled study. Scand J Infect Dis. 1993;25:31–5.PubMed Roos K, Holm SE, Grahn E, Lind L. Alpha-strepharyngo-tonsillitisococci as supplementary treatment of recurrent pharyngo-tonsillitis: a randomized placebo-controlled study. Scand J Infect Dis. 1993;25:31–5.PubMed
33.
go back to reference Roos K, Holm SE, Grahn-Hakansson E, Lagergren L. Recolonization with selected alpha- streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis – a randomized placebo-controlled multicentre study. Scand J Infect Dis. 1996;28:459–62.PubMedCrossRef Roos K, Holm SE, Grahn-Hakansson E, Lagergren L. Recolonization with selected alpha- streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis – a randomized placebo-controlled multicentre study. Scand J Infect Dis. 1996;28:459–62.PubMedCrossRef
34.
go back to reference Falck G, Grahn-Håkansson E, Holm SE, Roos K, Lagergren L. Tolerance and efficacy of interfering alpha- streptococcus in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol (Stockh). 1999;119:944–8.CrossRef Falck G, Grahn-Håkansson E, Holm SE, Roos K, Lagergren L. Tolerance and efficacy of interfering alpha- streptococcus in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol (Stockh). 1999;119:944–8.CrossRef
35.
go back to reference Brook I, Gober AE. Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxicillin-clavulanate. J Med Microbiol. 2005;54:553–6.PubMedCrossRef Brook I, Gober AE. Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxicillin-clavulanate. J Med Microbiol. 2005;54:553–6.PubMedCrossRef
36.
go back to reference Brook I, Gillmore JD. Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with Group A beta-hemolytic streptococcus. Antimicrob Agents Chemother. 1993;37:1452–5.PubMedCrossRef Brook I, Gillmore JD. Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with Group A beta-hemolytic streptococcus. Antimicrob Agents Chemother. 1993;37:1452–5.PubMedCrossRef
37.
go back to reference Brook I, Gober E. Recovery of interfering and beta-lactamase-producing bacteria from group A beta-haemolytic streptococci carriers and non-carriers. J Med Microbiol. 2006;55:1741–4.PubMedCrossRef Brook I, Gober E. Recovery of interfering and beta-lactamase-producing bacteria from group A beta-haemolytic streptococci carriers and non-carriers. J Med Microbiol. 2006;55:1741–4.PubMedCrossRef
38.
go back to reference Brook I, Gillmore JD. Enhancement of growth of Group A beta-hemolytic streptococcus in mixed infections with aerobic and anaerobic bacteria. Clin Microbiol Infect. 1996;1:179–82.PubMedCrossRef Brook I, Gillmore JD. Enhancement of growth of Group A beta-hemolytic streptococcus in mixed infections with aerobic and anaerobic bacteria. Clin Microbiol Infect. 1996;1:179–82.PubMedCrossRef
39.
go back to reference Brook I, Gober AE. Increased recovery of Moraxella catarrhalis and Haemophillus influenzae in association with Group A beta-hemolytic streptococcus in healthy children and those with pharyngo-tonsillitis. J Med Microb. 2006;55:989–92.CrossRef Brook I, Gober AE. Increased recovery of Moraxella catarrhalis and Haemophillus influenzae in association with Group A beta-hemolytic streptococcus in healthy children and those with pharyngo-tonsillitis. J Med Microb. 2006;55:989–92.CrossRef
40.
go back to reference Casey JR, Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of Group A streptococcal tonsillopharyngitis in adults. Clin Infect Dis. 2004;38:1526–34.PubMedCrossRef Casey JR, Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of Group A streptococcal tonsillopharyngitis in adults. Clin Infect Dis. 2004;38:1526–34.PubMedCrossRef
41.
go back to reference Pichichero ME. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatr Infect Dis J. 1993;12:268–74.PubMedCrossRef Pichichero ME. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatr Infect Dis J. 1993;12:268–74.PubMedCrossRef
42.
go back to reference Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Practice guidelines for the diagnosis and management of Group A streptococcal pharyngitis. 2012 update of the Infectious Diseases Society of America. Clin Infect Dis. 2012;55:1279–82.PubMedCrossRef Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Practice guidelines for the diagnosis and management of Group A streptococcal pharyngitis. 2012 update of the Infectious Diseases Society of America. Clin Infect Dis. 2012;55:1279–82.PubMedCrossRef
43.
go back to reference Brook I, Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to Group A beta-hemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin and clindamycin. Clin Pediatr. 1985;24:331–6.CrossRef Brook I, Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to Group A beta-hemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin and clindamycin. Clin Pediatr. 1985;24:331–6.CrossRef
44.
go back to reference Casey JR, Pichichero ME. Meta-analysis of short course antibiotic treatment for Group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 2005;24:909–17.PubMedCrossRef Casey JR, Pichichero ME. Meta-analysis of short course antibiotic treatment for Group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 2005;24:909–17.PubMedCrossRef
45.
go back to reference Brook I, Gober AE. Rate of eradication of Group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir. Int J Pediatr Otolaryngol. 2009;757–9. Brook I, Gober AE. Rate of eradication of Group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir. Int J Pediatr Otolaryngol. 2009;757–9.
46.
go back to reference Brook I, Foote PA. Efficacy of penicillin versus cefdinir in eradication of Group A streptococcal pharyngo-tonsillitis and tonsillar flora. Antimicrob Agents Chemother. 2005;49:4787–8.PubMedCrossRef Brook I, Foote PA. Efficacy of penicillin versus cefdinir in eradication of Group A streptococcal pharyngo-tonsillitis and tonsillar flora. Antimicrob Agents Chemother. 2005;49:4787–8.PubMedCrossRef
47.
go back to reference Breese BB, Disney FA, Talpey WB. Beta-hemolytic streptococcal illness: comparison of lincomycin, ampicillin, and potassium penicillin in treatment. Am J Dis Child. 1966;112:21–7.PubMed Breese BB, Disney FA, Talpey WB. Beta-hemolytic streptococcal illness: comparison of lincomycin, ampicillin, and potassium penicillin in treatment. Am J Dis Child. 1966;112:21–7.PubMed
48.
go back to reference Breese BB, Disney FA, Talpey WB, Green J. Beta-hemolytic streptococcal infection: comparison of penicillin and lincomycin in the treatment of recurrent infections of the carrier state. Am J Dis Child. 1969;117:14–527. Breese BB, Disney FA, Talpey WB, Green J. Beta-hemolytic streptococcal infection: comparison of penicillin and lincomycin in the treatment of recurrent infections of the carrier state. Am J Dis Child. 1969;117:14–527.
49.
go back to reference Randolph MF, DeHaan RM. A comparison of lincomycin and pencillin in the treatment of Group A streptococcal infection. Del Med J. 1969;41:51–62.PubMed Randolph MF, DeHaan RM. A comparison of lincomycin and pencillin in the treatment of Group A streptococcal infection. Del Med J. 1969;41:51–62.PubMed
50.
go back to reference Howie VM, Plousard JH. Treatment of group A streptococcal pharyngitis in children: comparison of lincomycin and penicillin G given orally and benzathine penicillin G given intramuscularly. Am J Dis Child. 1971;121:477–80.PubMed Howie VM, Plousard JH. Treatment of group A streptococcal pharyngitis in children: comparison of lincomycin and penicillin G given orally and benzathine penicillin G given intramuscularly. Am J Dis Child. 1971;121:477–80.PubMed
51.
go back to reference Randolph MF, Redys JJ, Hibbard EW. Streptococcal pharyngitis: III. Streptococcal recurrence rates following therapy with penicillin or with clindamycin (7-chlorolincomycin). Del Med J. 1970;42:87–92.PubMed Randolph MF, Redys JJ, Hibbard EW. Streptococcal pharyngitis: III. Streptococcal recurrence rates following therapy with penicillin or with clindamycin (7-chlorolincomycin). Del Med J. 1970;42:87–92.PubMed
52.
go back to reference Stillerman M, Isenberg HD, Facklam RR. Streptococcal pharyngitis therapy: comparison of clindamycin palmitate and potassium phenoxymethyl penicillin. Antimicrob Agents Chemother. 1973;4:514–20.PubMedCrossRef Stillerman M, Isenberg HD, Facklam RR. Streptococcal pharyngitis therapy: comparison of clindamycin palmitate and potassium phenoxymethyl penicillin. Antimicrob Agents Chemother. 1973;4:514–20.PubMedCrossRef
53.
go back to reference Chaudhary S, Bilinsky SA, Hennessy JL, Soler SM, Wallace SE, Schacht CM, et al. Penicillin V and rifampin for the treatment of Group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy. J Pediatr. 1985;106:481–6.PubMedCrossRef Chaudhary S, Bilinsky SA, Hennessy JL, Soler SM, Wallace SE, Schacht CM, et al. Penicillin V and rifampin for the treatment of Group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy. J Pediatr. 1985;106:481–6.PubMedCrossRef
54.
go back to reference Smith TD, Huskins WC, Kim KS, Kaplan EL. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin in eradicating streptococci for the pharynx after failure of penicillin therapy for Group A streptococcal pharyngitis. J Pediatr. 1987;110:777–82.PubMedCrossRef Smith TD, Huskins WC, Kim KS, Kaplan EL. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin in eradicating streptococci for the pharynx after failure of penicillin therapy for Group A streptococcal pharyngitis. J Pediatr. 1987;110:777–82.PubMedCrossRef
55.
go back to reference Orrling A, Stjernquist-Desatnik A, Schalen C, Kamme C. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment. Scand J Infect Dis. 1994;26:535–41.PubMedCrossRef Orrling A, Stjernquist-Desatnik A, Schalen C, Kamme C. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment. Scand J Infect Dis. 1994;26:535–41.PubMedCrossRef
56.
go back to reference Mahakit P, Vicente JG, Butt DI, Angeli G, Bansal S, Zambrano D. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. Clin Ther. 2006;28:99–109.PubMedCrossRef Mahakit P, Vicente JG, Butt DI, Angeli G, Bansal S, Zambrano D. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. Clin Ther. 2006;28:99–109.PubMedCrossRef
Metadata
Title
Penicillin Failure in the Treatment of Streptococcal Pharyngo-Tonsillitis
Author
Itzhak Brook
Publication date
01-06-2013
Publisher
Current Science Inc.
Published in
Current Infectious Disease Reports / Issue 3/2013
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-013-0338-0

Other articles of this Issue 3/2013

Current Infectious Disease Reports 3/2013 Go to the issue

Tropical, Travel and Emerging Infections (L Chen, Section Editor)

Schistosomiasis: Current Epidemiology and Management in Travelers

Pediatric Infectious Diseases (I Brook, Section Editor)

Fusobacterial Infections in Children

Pediatric Infectious Diseases (I Brook, Section Editor)

Treatment and Prevention of Rotavirus Infection in Children

Pediatric Infectious Diseases (I Brook, Section Editor)

Probiotics and Prebiotics in Infants and Children

Pediatric Infectious Diseases (I Brook, Section Editor)

Reducing Central Line Infections in Pediatric and Neonatal Patients